Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Not pending/lapsed |
21 | DE file number | DAKZ | 599 00 581.5 |
96 | EP file number | EAKZ | 99 91 0359.1 |
86 | WO file number | WAKZ | PCT/EP99/01795 |
97 | EP publication number | EPN | 1033978 |
87 | WO publication number | WPN | 1999049852 |
54 | Designation/title | TI | D2-AGONIST ENTHALTENDES TRANSDERMALES THERAPEUTISCHES SYSTEM ZUR BEHANDLUNG DES PARKINSON-SYNDROMS UND VERFAHREN ZU SEINER HERSTELLUNG |
51 | IPC main class | ICM (ICMV) | A61K 9/70 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | C07D 333/20 (2006.01) |
22 | DE application date | DAT | Mar 18, 1999 |
96 | EP application date | EAT | Mar 18, 1999 |
86 | WO application date | WAT | Mar 18, 1999 |
43 | Date of first publication | OT | Oct 7, 1999 |
| Date of publication of grant | PET | Dec 19, 2001 |
71/73 | Applicant/owner | INH | LTS Lohmann Therapie-Systeme AG, 56626 Andernach, DE; UCB Biopharma SPRL, Brüssel, BE |
72 | Inventor | IN | MÜLLER, Walter, W-5656 Neuwied, DE; PECK V., James, Richmond, US |
74 | Representative | VTR | Flaccus, Rolf Dieter, Dipl.-Chem. Dr.rer.nat., 50389 Wesseling, DE |
| Address for service | | Patentanwälte FLACCUS MÜLLER-WOLFF, 50389 Wesseling, DE |
66 66
| Domestic priority | PRN PRD
| 19814084 Mar 30, 1998
|
| Patent division in charge | | 44 |
21 | File number of protection certificate | ZAKZ | 12 2006 000 035.6 |
97 | EP language of publication | ELANG | DE - Deutsch |
87 | WO language of publication | WLANG | DE - Deutsch |
84 | Designated EP contracting states | EDS | AT, BE, CH, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, NL, PT, SE |
81 | Designated WO countries | WDS | SI |
| Published EP/WO documents | EPWOPN | Original document:
EP000001033978 Searchable text:
EP000001033978 Original document:
EP000001033978B1 Searchable text:
EP000001033978B1 Original document:
WO001999049852 Searchable text:
WO001999049852 |
43 | Date of first publication | EVT | Oct 7, 1999 |
| Date of the first transfer into DPMAregister | EREGT | Sep 27, 2012 |
| Date of the (most recent) update in DPMAregister | REGT | Aug 13, 2019 (Show all update days)(Hide all update days)- Aug 13, 2019; Mar 20, 2019; Oct 29, 2018; Apr 6, 2018; Jul 27, 2017; Jun 15, 2017; Apr 4, 2017; Mar 31, 2016; Aug 25, 2015; Apr 9, 2015; Mar 27, 2015; Apr 9, 2014; Mar 26, 2014; Sep 24, 2013; Aug 2, 2013; Jun 20, 2013; Jun 8, 2013; Jun 4, 2013; May 25, 2013; Apr 27, 2013; Apr 24, 2013; Apr 23, 2013; Apr 19, 2013; Apr 11, 2013; Mar 30, 2013; Feb 15, 2013; Feb 14, 2013; Feb 13, 2013; Feb 5, 2013; Jan 4, 2013; Dec 26, 2012; Dec 1, 2012; Nov 29, 2012; Nov 17, 2012; Nov 16, 2012; Nov 15, 2012; Nov 13, 2012; Oct 9, 2012; Oct 2, 2012; Oct 1, 2012
- Historical data not available for this/these date(s)
- Sep 27, 2012
- Date of the first transfer into DPMAregister
|
View procedures New applicant/owner details (No.: 8)INID | Criterion | Field | Content
Close details
|
---|
| Type of procedure | VART | New applicant/owner details |
| Legal/procedural status | VST | New applicant/owner details |
| Date of legal/procedural status | VSTT | Jan 29, 2003 |
| Issue number | HN | 14 |
| Year | PJ | 2003 |
| Publication date | VT | Apr 3, 2003 |
| Type of publication | PART | Bibliographic data |
| Part | HT | Part 3 |
71/73 | Applicant/owner | INH | LTS Lohmann Therapie-Systeme AG, 56626 Andernach, DE; Aderis Pharmaceuticals, Inc. (n.d.Ges.d. Staates Delaware), Richmond, Va., US |
71/73 | Previous applicant/owner | INHF | LTS Lohmann Therapie-Systeme AG, 56626 Andernach, DE, Discovery Therapeutics, Inc., Richmond, Va., US |
View procedures New applicant/owner details (No.: 10)INID | Criterion | Field | Content
Close details
|
---|
| Type of procedure | VART | New applicant/owner details |
| Legal/procedural status | VST | New applicant/owner details |
| Date of legal/procedural status | VSTT | Jul 26, 2006 |
| Issue number | HN | 39 |
| Year | PJ | 2006 |
| Publication date | VT | Sep 28, 2006 |
| Type of publication | PART | Bibliographic data |
| Part | HT | Part 3 |
71/73 | Applicant/owner | INH | LTS Lohmann Therapie-Systeme AG, 56626 Andernach, DE; Schwarz Pharma Ltd., Schannon, County Clare, IE |
71/73 | Previous applicant/owner | INHF | LTS Lohmann Therapie-Systeme AG, 56626 Andernach, DE, Aderis Pharmaceuticals, Inc. (n.d.Ges.d. Staates Delaware), Richmond, Va., US |
View procedures New applicant/owner details (No.: 11)INID | Criterion | Field | Content
Close details
|
---|
| Type of procedure | VART | New applicant/owner details |
| Legal/procedural status | VST | New applicant/owner details |
| Date of legal/procedural status | VSTT | Apr 26, 2013 |
| Issue number | HN | 25 |
| Year | PJ | 2013 |
| Publication date | VT | Jun 20, 2013 |
| Type of publication | PART | Bibliographic data |
| Part | HT | Part 2 |
71/73 | Applicant/owner | INH | LTS Lohmann Therapie-Systeme AG, 56626 Andernach, DE; UCB Manufacturing Ireland Ltd., Shannon, County Clare, IE |
71/73 | Previous applicant/owner | INHF | LTS Lohmann Therapie-Systeme AG, 56626 Andernach, DE, Schwarz Pharma Ltd., Schannon, County Clare, IE |